Projections of cancer incidence and burden among the HIV-positive population in the United States

Jessica Yasmine Islam speaks with ecancer at AACR 2017 about the changing burden of disease for HIV citizens who develop cancer.

She notes the increased availability of life-extending anti-retroviral drugs, resulting in HIV patients living long enough to increase their risk of developing non-AIDS related cancers, and that by 2030 over 20% of HIV patients are projected to live over 65 years.